Yes, I do. Allo-SCT may be curative for 10-20% of patients with refractory multiple myeloma and a larger proportion of patients who are transplanted early in their disease course. The key is the allo transplant and the intense pre transplant treatment. Again, this is not for everyone. Generally useful in patient under 65 who are healthy and where the disease has been caught early. Unfortunately, thats not mant patients.